BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2016
View Archived Issues
Lycera studies LYC-55716 in phase I/IIa trial in locally advanced or metastatic cancer
Read More
Targeting the NK-1 receptor has antispastic effects after chronic spinal injury
Read More
PF-06648671 reduces cerebrospinal fluid amyloid-beta after single and multiple doses
Read More
ROSGard demonstrates renal protective effect during radiation therapy
Read More
Amgen patents appelin receptor agonists
Read More
EMA validates Oxervate MAA for neurotrophic keratitis
Read More
BioMarin Pharmaceutical begins phase III study of vosoritide in achondroplasia
Read More
Flexion Therapeutics submits NDA to FDA for Zilretta
Read More
Metabolite profiling shows anandamide is linked to nonalcoholic steatohepatitis in obesity
Read More
Purdue Pharma and Exicure enter collaboration agreement in psoriasis
Read More
Achaogen reports favorable results from phase III trials of plazomicin
Read More
University of Michigan discloses cyclic peptides
Read More
Idenix Pharmaceuticals describes prodrugs of gemcitabine
Read More
Almirall and Nuevolution to jointly develop RORgammat inhibitors
Read More
Pharmascience develops TEC kinase inhibitors
Read More
Eiger BioPharmaceuticals reports interim results from phase II study of exendin 9-39 in PBH
Read More
First preclinical data for LOXO-195
Read More
Novel model reveals roles of Iroquois homeobox proteins in left ventricular noncompaction
Read More
M-DGN-549: a new ADC for cancer
Read More
Preclinical data on TPC-144 for the treatment of AML and SCLC
Read More
Phase II data show efficacy of pembrolizumab for cutaneous T-cell lymphomas
Read More
Bayer and Versant Ventures establish BlueRock Therapeutics
Read More
Phase IIa results further support potential of RedHill Biopharma's RHB-104 in multiple sclerosis
Read More
Defymed collaborates with Semma Therapeutics to develop innovative treatment for type 1 diabetes
Read More
Revance reports interim data from phase II study of RT-002 in cervical dystonia
Read More
Arimoclomol shows safety and efficacy in phase II trial in patients with ALS due to SOD1 mutation
Read More
IGNITE Immunotherapy launches, will focus on oncolytic virus vaccines with lead investor, Pfizer
Read More
Astellas Pharma transfers Qutenza to Grunenthal
Read More
MeiraGTx expands pipeline with program targeting retromer
Read More
EC grants marketing authorization to Arzerra in combination with FC for CLL
Read More